drugset / Trial / NCT00073203

A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

NCT00073203

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to determine the effectiveness of 2 target doses of R228060 in comparison with placebo during 6 weeks of treatment in moderately to severely depressed adult subjects with major depressive disorder. Approximately 488 subjects will be involved in the study.

Timeline

Start
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule
Subject Solriamfetol Small molecule